276
Views
15
CrossRef citations to date
0
Altmetric
Reviews

A review of economic impact of targeted oral anticancer medications

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Monia Marchetti. (2017) Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 469-480.
Read now
L. Benjamin, R. Maroun, F. Maurel, I. Bardoulat & C. Ricarte. (2015) Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study). Current Medical Research and Opinion 31:2, pages 323-332.
Read now
Daniel M Geynisman, Chun-Ru Chien, Fabrice Smieliauskas, Chan Shen & Ya-Chen Tina Shih. (2014) Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review. Human Vaccines & Immunotherapeutics 10:11, pages 3415-3424.
Read now

Articles from other publishers (11)

Elisabeth M. Smale, Bas van Vlijmen, Hadewig B.B. Colen, Michel M. van den Heuvel, Ingrid M.E. Desar, Bart J.F. van den Bemt & Charlotte L. Bekker. (2023) Feasibility of an Individualized Dispensing Program for Patients Prescribed Oral Anticancer Drugs to Prevent Waste. JCO Oncology Practice.
Crossref
Amy J Davidoff, Kaitlin Akif & Michael T Halpern. (2022) Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature. JNCI Monographs 2022:59, pages 12-20.
Crossref
Yichen Shen & Haruko Noguchi. (2021) Impacts of anticancer drug parity laws on mortality rates. Social Science & Medicine 272, pages 113714.
Crossref
Tatiane Bomfim Ribeiro, Adalton Ribeiro, Luíza de Oliveira Rodrigues, Guilherme Harada & Moacyr Roberto Cuce Nobre. (2019) U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer. International Journal of Technology Assessment in Health Care 36:1, pages 20-28.
Crossref
Ahmad Al Kadour, Wafa Al Marridi & Daoud Al-Badriyeh. (2018) Pharmacoeconomics Evaluations of Oral Anticancer Agents: Systematic Review of Characteristics, Methodological Trends, and Reporting Quality. Value in Health Regional Issues 16, pages 46-60.
Crossref
Ming-Horng Tsai, Ju-Fang Liu, Yao-Chang Chiang, Stephen Chu-Sung Hu, Lee-Fen Hsu, Yu-Ching Lin, Zih-Chan Lin, Hui-Chun Lee, Mei-Chuan Chen, Chieh-Liang Huang & Chiang-Wen Lee. (2017) Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells. Oncotarget 8:17, pages 28342-28358.
Crossref
Andreas Lundh, Joel Lexchin, Barbara Mintzes, Jeppe B Schroll & Lisa Bero. (2017) Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2017:2.
Crossref
Chan Shen, Bo Zhao, Lei Liu & Ya-Chen Tina Shih. (2017) Financial Burden for Patients With Chronic Myeloid Leukemia Enrolled in Medicare Part D Taking Targeted Oral Anticancer Medications. Journal of Oncology Practice 13:2, pages e152-e162.
Crossref
Jeffrey Betcher, Elizabeth Dow & Nandita Khera. (2016) Oral Chemotherapy in Patients with Hematological Malignancies—Care Process, Pharmacoeconomic and Policy Implications. Current Hematologic Malignancy Reports 11:4, pages 288-294.
Crossref
Chun-Ru Chien, Te-Chun Hsia & Chih-Yi Chen. (2014) Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis. Thoracic Cancer 5:6, pages 530-536.
Crossref
Fabrice Smieliauskas, Chun-Ru Chien, Chan Shen, Daniel M. Geynisman & Ya-Chen Tina Shih. (2014) Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review. PharmacoEconomics 32:7, pages 651-680.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.